相关实验视频

Updated: Feb 28, 2026

Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration

Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration

Published on: February 28, 2013

大规模的等离子体蛋白质组学和基因整合揭示了男性发模式中的新生物学途径

Lingfeng Pan¹, Caihong Li², Philipp Moog¹

¹Clinic for Plastic, Reconstructive and Hand Surgery, Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany.

International journal of molecular sciences

|February 27, 2026

概括

这项研究确定了参与男性发 (MPB) 的关键蛋白质和途径,揭示了新的非荷尔蒙治疗点,如脱发治疗的CD38.

科学领域:

遗传学和分子生物学
皮肤病学皮肤病学

背景情况:

男人发 (MPB) 很常见,但其分子基础不明,阻碍了新的治疗方法.
目前的疗法往往侧重于雄激素信号传递,限制了创新.

研究的目的:

识别和优先考虑因果蛋白和涉及男性模式发 (MPB) 的途径.
为了弥合遗传关联和生物功能之间的差距,用于治疗开发.

主要方法:

在24,069名英国生物库参与者中,对2911种血蛋白进行全蛋白质组关联研究 (PWAS).
路径丰富分析,多组合集成和转录组全域关联研究 (TWAS).
验证使用头皮活检的转录和评估药物可用性和性.

主要成果:

47种与MPB严重程度显著相关的蛋白质,富含毛发循环和表皮发育途径.
五个候选基因被优先考虑:CD38,FGF5,TACSTD2,DPEP1,PLB1. 这五个候选基因被优先考虑:CD38,FGF5,TACSTD2,DPEP1,PLB1.
CD38 (上调) 和TACSTD2,PLB1 (下调) 在头皮变方面表现不同;CD38是一种可用药物的标.

结论:

阐明了MPB的分子架构,超出了雄激素信号传递.
确定新的生物途径,并优先考虑非荷尔蒙点,如脱发疗法中的CD38.
为开发新型男性发治疗提供基于证据的框架.

关键词:

遗传学遗传学遗传学是一个炎症导致的炎症.男性的模式发,男性发.蛋白质组学蛋白质组学治疗目标是治疗的目标.

更多相关视频

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...